TRACON Pharmaceuticals, Inc. (TCON)
OTCMKTS: TCON · Delayed Price · USD
0.631
+0.030 (4.99%)
Jul 22, 2024, 9:58 AM EDT - Market open
TRACON Pharmaceuticals Employees
TRACON Pharmaceuticals had 17 employees as of December 31, 2023. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
$714,412
Profits / Employee
$102,824
Market Cap
1.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
TCON News
- 5 weeks ago - TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients - GlobeNewsWire
- 2 months ago - TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - GlobeNewsWire
- 3 months ago - TRACON Pharmaceuticals Announces Reverse Stock Split - GlobeNewsWire
- 4 months ago - TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024 - GlobeNewsWire
- 7 months ago - TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial - GlobeNewsWire
- 8 months ago - TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment - GlobeNewsWire